SIMILAR PATTERNS OF AMINO ACIDS FOR 4PL1_A_SAMA401_0
List of similar pattern of amino acids derived from ASSAM searchHit | Macromolecule/ Organism |
Pfam | Res. | Interface | HETATM | RMSD | Dali Z-score | Seq. Identity (%) | View | Dock | |
---|---|---|---|---|---|---|---|---|---|---|---|
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2e4u | METABOTROPICGLUTAMATE RECEPTOR 3 (Rattusnorvegicus) |
PF01094(ANF_receptor)PF07562(NCD3G) | 5 | PHE A 187PRO A 46SER A 173ILE A 155ASN A 159 | NoneNoneGLU A 701 (-4.5A)NoneNone | 1.39A | 4pl1A-2e4uA:1.4 | 4pl1A-2e4uA:20.04 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 2wwe | PHOSPHOINOSITIDE-3-KINASE, CLASS 2,GAMMA POLYPEPTIDE (Homo sapiens) |
PF00787(PX) | 5 | GLU A1306SER A1232HIS A1226ILE A1204ASN A1295 | None | 1.49A | 4pl1A-2wweA:0.0 | 4pl1A-2wweA:14.89 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3mq4 | METABOTROPICGLUTAMATE RECEPTOR 7 (Homo sapiens) |
PF01094(ANF_receptor) | 5 | PHE A 195PRO A 56SER A 181ILE A 163ASN A 167 | NoneNoneZ99 A 514 (-4.6A)NoneNone | 1.32A | 4pl1A-3mq4A:2.0 | 4pl1A-3mq4A:20.28 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 3sm9 | METABOTROPICGLUTAMATE RECEPTOR 3 (Homo sapiens) |
PF01094(ANF_receptor) | 5 | PHE A 162PRO A 21SER A 148ILE A 130ASN A 134 | None CL A 486 ( 3.9A)Z99 A 485 (-4.6A)NoneSO4 A 480 (-3.4A) | 1.36A | 4pl1A-3sm9A:1.9 | 4pl1A-3sm9A:22.95 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 4nji | 7-CARBOXY-7-DEAZAGUANINE SYNTHASE (Burkholderiamultivorans) |
PF13394(Fer4_14) | 5 | PHE A 48GLU A 116SER A 133ILE A 152ASN A 183 | SAM A 302 (-4.8A)2K8 A 303 ( 3.9A)SAM A 302 (-2.8A)NoneNone | 1.36A | 4pl1A-4njiA:7.5 | 4pl1A-4njiA:22.68 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4pl2 | DUAL-SPECIFICITY RNAMETHYLTRANSFERASERLMN (Escherichiacoli) |
no annotation | 7 | PHE B 131GLU B 180PRO B 181SER B 211HIS B 235ILE B 309TRP B 311 | SF4 B 401 ( 4.6A)SF4 B 401 ( 4.8A)NoneNoneNoneNoneNone | 0.64A | 4pl1A-4pl2B:50.8 | 4pl1A-4pl2B:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4pl2 | DUAL-SPECIFICITY RNAMETHYLTRANSFERASERLMN (Escherichiacoli) |
no annotation | 7 | PHE B 131GLU B 180PRO B 181SER B 211SER B 233HIS B 235ILE B 309 | SF4 B 401 ( 4.6A)SF4 B 401 ( 4.8A)NoneNoneSF4 B 401 ( 4.8A)NoneNone | 0.48A | 4pl1A-4pl2B:50.8 | 4pl1A-4pl2B:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4pl2 | DUAL-SPECIFICITY RNAMETHYLTRANSFERASERLMN (Escherichiacoli) |
no annotation | 5 | PHE B 131HIS B 235GLU B 278ILE B 309TRP B 311 | SF4 B 401 ( 4.6A)NoneNoneNoneNone | 0.99A | 4pl1A-4pl2B:50.8 | 4pl1A-4pl2B:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4pl2 | DUAL-SPECIFICITY RNAMETHYLTRANSFERASERLMN (Escherichiacoli) |
no annotation | 7 | PHE B 131MET B 176GLU B 180PRO B 181SER B 211SER B 233ILE B 309 | SF4 B 401 ( 4.6A)NoneSF4 B 401 ( 4.8A)NoneNoneSF4 B 401 ( 4.8A)None | 0.72A | 4pl1A-4pl2B:50.8 | 4pl1A-4pl2B:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4pl2 | DUAL-SPECIFICITY RNAMETHYLTRANSFERASERLMN (Escherichiacoli) |
no annotation | 5 | PHE B 131MET B 176SER B 233GLU B 278ILE B 309 | SF4 B 401 ( 4.6A)NoneSF4 B 401 ( 4.8A)NoneNone | 1.16A | 4pl1A-4pl2B:50.8 | 4pl1A-4pl2B:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 4pl2 | DUAL-SPECIFICITY RNAMETHYLTRANSFERASERLMN (Escherichiacoli) |
no annotation | 5 | PHE B 131SER B 233HIS B 235GLU B 278ILE B 309 | SF4 B 401 ( 4.6A)SF4 B 401 ( 4.8A)NoneNoneNone | 0.91A | 4pl1A-4pl2B:50.8 | 4pl1A-4pl2B:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5cni | METABOTROPICGLUTAMATE RECEPTOR 2 (Homo sapiens) |
PF01094(ANF_receptor) | 5 | PHE A 181PRO A 39SER A 167ILE A 149ASN A 153 | None CL A 602 ( 4.0A)GGL A 601 (-4.5A)NoneNone | 1.37A | 4pl1A-5cniA:1.6 | 4pl1A-5cniA:20.66 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hr6 | RLMN METHYLASE (Escherichiacoli) |
PF04055(Radical_SAM) | 10 | PHE A 131MET A 176GLU A 180PRO A 181SER A 211SER A 233HIS A 235ILE A 309TRP A 311ASN A 312 | 5AD A 503 (-4.6A) A C 37 ( 3.7A)MET A 501 (-4.0A)MET A 501 ( 4.9A)MET A 501 (-2.5A)MET A 501 ( 2.6A)5AD A 503 (-3.7A)5AD A 503 (-4.1A)5AD A 503 (-4.0A)SMC A 355 (-3.7A) | 0.46A | 4pl1A-5hr6A:49.5 | 4pl1A-5hr6A:100.00 | ||
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target. | 5hr6 | RLMN METHYLASE (Escherichiacoli) |
PF04055(Radical_SAM) | 7 | PHE A 131MET A 176HIS A 235GLU A 278ILE A 309TRP A 311ASN A 312 | 5AD A 503 (-4.6A) A C 37 ( 3.7A)5AD A 503 (-3.7A)5AD A 503 (-3.1A)5AD A 503 (-4.1A)5AD A 503 (-4.0A)SMC A 355 (-3.7A) | 0.88A | 4pl1A-5hr6A:49.5 | 4pl1A-5hr6A:100.00 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5kzn | METABOTROPICGLUTAMATE RECEPTOR 2 (Homo sapiens) |
PF01094(ANF_receptor)PF07562(NCD3G) | 5 | PHE A 181PRO A 39SER A 167ILE A 149ASN A 153 | None | 1.31A | 4pl1A-5kznA:1.8 | 4pl1A-5kznA:21.37 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 5ubp | LEUCINE PERMEASETRANSCRIPTIONALREGULATOR (Saccharomycescerevisiae) |
PF03399(SAC3_GANP) | 5 | PHE A 282GLU A 208PRO A 205ILE A 268ASN A 271 | None | 1.38A | 4pl1A-5ubpA:undetectable | 4pl1A-5ubpA:21.26 | ||
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site. | 6bsz | METABOTROPICGLUTAMATE RECEPTOR 8 (Homo sapiens) |
no annotation | 5 | PHE A 192PRO A 53SER A 178ILE A 160ASN A 164 | NoneNoneGGL A 601 (-4.6A)NoneNone | 1.34A | 4pl1A-6bszA:1.0 | 4pl1A-6bszA:undetectable |